Abrams Eye Center — research payments reported

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$8,020	1
2021	Research	$158,379	11
2020	Research	$8,876	3
2019	Research	$13,641	5

Breakdown

Who paid Research payments · program years 2019–2022

Bausch Health US, LLC $82,150 5 payments
Novartis Pharmaceuticals Corporation $65,205 2 payments
Ocular Therapeutix, Inc. $23,300 7 payments
Kala Pharmaceuticals, Inc. $13,180 4 payments
Osmotica Pharmaceutical Corp. $5,081 2 payments

Studies the money was for Research payments · program years 2019–2022

A Phase 3, Multi-Center, Randomized, Double-Masked, Saline-Controlled Trial to Evaluate the Effect of NOV03 (Perfluorohexyloctane) on Signs and Symptoms of Dry Eye Disease Associated with Meibomian Gland Dysfunction (Mojave Study) $82,150 5 payments
A Randomized, Double-Masked, Multicenter Study to Evaluate the Safety and Efficacy of Ecf843 VS Vehicle in Subjects With Dry Eye Disease $65,205 2 payments
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease $13,180 4 payments
A Randomized, Multi-center, Double-masked, Vehicle-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI (Cyclosporine Ophthalmic Insert) for Intracanalicular Use for the Treatment of Subjects With Dry Eye Disease (DED) $12,780 5 payments
A Randomized, Multi-center, Double-masked, Vehicle-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of OTX-CSI (Cyclosporine Ophthalmic Insert) for Intracanalicular Use for the Treatment of Subjects With Dry Eye Disease (DED) $8,020 1 payment
Rvl-203 $5,081 2 payments
A Randomized Multi center Double masked Vehicle controlled phase 1 phase 2 Study to Evaluate the Safety Tolerability and Efficacy of OTX CSI for Intracanalicular Use for the Treatment of Subjects With Dry Eye Disease $2,500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.